Insider Cluster (9 insiders) ·Filed May 28, 2026

EXEL

EXELIXIS, INC.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $3.8M total
Actionable Insight • Neutral

The insider sales are too small relative to market cap to warrant a bearish read. Monitor for any material corporate events (e.g., earnings, pipeline updates) that could explain the timing, but no immediate action is needed.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
EXEL ▲ +8.17% at T+60d
NEUTRAL call ✓ call won +8.17% · α vs SPY +7.24% · entry $50.32 → $54.43
Entry anchored
May 28, 03:59 PM ET
via exchange tick
T+1d
-0.08%
call -0.08% · α -0.35%
$50.28
settled 4mo ago
T+5d
+2.55%
call +2.55% · α +2.84%
$51.60
settled 4mo ago
T+20d
+8.85%
call +8.85% · α +12.48%
$54.77
settled 3mo ago
T+60d
+8.17%
call +8.17% · α +7.24%
$54.43
settled 6w ago

Price Chart

Loading chart...

Executive Summary

Two EVPs at Exelixis sold a combined $3.79M in open-market sales over a week, while seven directors received non-cash stock grants. The sales represent ~0.03% of market cap, which is trivial relative to the $12.9B company. The cluster is driven by C-suite selling, but the dollar amount is immaterial and likely reflects routine portfolio diversification rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$3.8M
Insiders
9

Key Facts

  • EVP Patrick J. Haley sold 32,100 shares at $49.81 for $1.60M on 2026-05-20
  • EVP Dana Aftab sold 43,451 shares at $50.35 for $2.19M on 2026-05-26
  • Seven directors received non-cash stock grants totaling 69,335 shares at $0 on 2026-05-27
  • Total open-market sales of $3.79M represent ~0.03% of Exelixis's $12.9B market cap
  • No insider open-market purchases were reported in the cluster

Financial Impact

Open-market sales of $3.79M, or ~0.03% of market cap — immaterial

dilution

Risk Factors

  • C-suite selling could indicate private concerns not yet public, though dollar amount is trivial
  • No insider buying to offset the selling signal

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
58% bullish (26 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-EXEL-1780091011818
12 reports for EXEL
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+60▲ +21.97%Feb 28, 2026
Filters
Rows
Reports for EXEL — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
8-K
BEARISH ★ 6/10
$56.12 $58.36▼ −3.99%▼ −4.21%$58.40 (−4.06%)
Aug 10, 2026
7w ago
Press Release
BEARISH ★ 7/10
$51.33 $53.10▼ −3.44%▼ −3.85%$58.40 (−13.77%)
Jun 3, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$52.39 $53.50▲ +2.12%▲ +4.68%$58.40 (+11.48%)
May 29, 2026
17w ago
8-K
NEUTRAL ★ 3/10
$50.20 $52.70▲ +4.98%▲ +7.73%$58.40 (+16.34%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $51.60▲ +2.55%▲ +2.84%$58.40 (+16.06%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $51.60▲ +2.55%▲ +2.84%$58.40 (+16.06%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$50.32 $52.69▲ +4.71%▲ +7.23%$58.40 (+16.06%)
May 22, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.94 $48.49▼ −2.90%▼ −4.12%$58.40 (+16.95%)
May 19, 2026
19w ago
Insider Cluster
NEUTRAL ★ 3/10
$49.89 $51.46▲ +3.15%▲ +1.34%$58.40 (+17.06%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$46.10 $51.29▲ +11.26%▲ +9.76%$58.40 (+26.69%)
Showing 10 of 12

US Market Status

Market Open — Closes in 3h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 29, 2026